Micrima

Bristol, United Kingdom Founded: 2005 • Age: 21 yrs
Breast cancer is detected via non-invasive radio wave technology.
Request Access

About Micrima

Micrima is a company based in Bristol (United Kingdom) founded in 2005 by Roy Johnson. It operates as a HealthTech. Micrima has raised $19.34 million across 9 funding rounds from investors including University of Bristol, Nesta and YFM Equity Partners. The company has 25 employees as of December 31, 2020. Micrima offers products and services including Mi~Scan® and Mi~Scan®+. Micrima operates in a competitive market with competitors including Vayyar, Niramai, CairnSurgical, UE LifeSciences and CMR Naviscan, among others.

  • Headquarter Bristol, United Kingdom
  • Employees 25 as on 31 Dec, 2020
  • Founders Roy Johnson
  • Stage Minicorn
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Micrima Limited
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $19.34 M (USD)

    in 9 rounds

  • Latest Funding Round
    $13.97 K (USD), Series A

    Apr 21, 2021

  • Investors
  • Employee Count
    25

    as on Dec 31, 2020

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Micrima

Micrima offers a comprehensive portfolio of products and services, including Mi~Scan® and Mi~Scan®+. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Breast density is measured non-invasively without harmful radiation.

Personalized risk profile is provided for breast cancer.

People of Micrima
Headcount 10-50
Employee Profiles 7
Employee Profiles
People
Adrian Waller
Chief Executive Officer
People
Andrew Wood
Chief Financial Officer
People
Brandon Corbett
Senior Research And Development Engineer
People
Leigh Cornock
Chief Technology Officer (CTO)

Unlock access to complete

Funding Insights of Micrima

Micrima has successfully raised a total of $19.34M across 9 strategic funding rounds. The most recent funding activity was a Series A round of $13.97 thousand completed in April 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 9
  • Last Round Series A — $13,966
  • First Round

    (05 Dec 2005)

  • Investors Count 9
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2021 Amount Series A - Micrima Valuation Greenwood Way Capital
Mar, 2018 Amount Series A - Micrima Valuation Technology Venture Partners , VentureFounders
Aug, 2016 Amount Series A - Micrima Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Micrima

Micrima has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include University of Bristol, Nesta and YFM Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Early stage tech companies are introduced to suitable investors.
Founded Year Domain Location
Venture capital is provided to innovative technology companies.
Founded Year Domain Location
Tech startups receive investments from this London-based venture capital firm.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Micrima

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Micrima

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Micrima Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Micrima

Micrima operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Vayyar, Niramai, CairnSurgical, UE LifeSciences and CMR Naviscan, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Developer of 4D imaging sensors for cancer detection and other devices
domain founded_year HQ Location
Early breast cancer is detected using AI-based non-invasive thermal imaging.
domain founded_year HQ Location
Developer of 3D printed surgical guides for breast cancer treatment
domain founded_year HQ Location
Non-invasive devices for breast and cervical cancer screening are provided.
domain founded_year HQ Location
High-resolution PET scanners for breast imaging are developed and manufactured.
domain founded_year HQ Location
Intraoperative cancer detection devices are developed for real-time tissue assessment.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Micrima

Frequently Asked Questions about Micrima

When was Micrima founded?

Micrima was founded in 2005.

Where is Micrima located?

Micrima is headquartered in Bristol, United Kingdom. It is registered at Bristol, England, United Kingdom.

Is Micrima a funded company?

Micrima is a funded company, having raised a total of $19.34M across 9 funding rounds to date.

How many employees does Micrima have?

As of Dec 31, 2020, the latest employee count at Micrima is 25.

What does Micrima do?

Micrima is engaged in developing non-invasive breast cancer risk assessment tools. Solutions like MiScan and MiScan are offered to measure breast density and provide personalized risk profiles. The healthcare sector is primarily targeted, with an emphasis on early detection support. Women of all ages are served without the need for referrals. Harmful radiation and compression are avoided in the scanning process. Statistical risk information is provided to empower health decisions.

Who are the top competitors of Micrima?

Micrima's top competitors include CairnSurgical, Niramai and UE LifeSciences.

What products or services does Micrima offer?

Micrima offers Mi~Scan® and Mi~Scan®+.

Who are Micrima's investors?

Micrima has 9 investors. Key investors include University of Bristol, Nesta, YFM Equity Partners, GWC, and Technology Venture Partners.

What is Micrima's valuation?

The valuation of Micrima is $13.87M as of Apr 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available